From Harvard Medical School (Drs. Lizano, Scharf, Berman, Widge, Dougherty, and Eskandar); Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA (Dr. Lizano); Department of Counseling and Applied Education, Northeastern University (Ms. Popat-Jain); Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetics Research, Departments of Neurology and Psychiatry (Dr. Scharf), Division of Movement Disorders, Department of Neurology (Dr. Scharf), OCD and Related Disorders Program (Dr. Berman), TranslationalNeuroEngineering Laboratory (Dr. Widge) and Division of Neurotherapeutics (Drs. Widge and Dougherty), Department of Psychiatry, and Functional Neurosurgery (Dr. Eskandar), Massachusetts General Hospital, Boston, MA; Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women’s Hospital, Boston, MA (Dr. Scharf).
Correspondence: Paulo Lizano MD, PhD, 221 Longwood Ave., Boston, MA 02115. Email: firstname.lastname@example.org